SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-105193
Filing Date
2024-09-10
Accepted
2024-09-10 16:49:08
Documents
2
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2223
2 EX-24 tyra-ex24.htm EX-24 13262
  Complete submission text file 0000950170-24-105193.txt   16917
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Issuer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EFFECTOR THERAPEUTICS, INC. 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address
Warner Douglas J (Reporting) CIK: 0001941311 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40800 | Film No.: 241290591